NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.
Company’s Keywords:
cardiac surgery, cardiology, interventional cardiology, physician, medical device, mitral valve repair, fellows, clinical research
23
medical devices
6000000
Sendgrid, Outlook, Microsoft Office 365, DigitalOcean, Media Temple SSL, Google Tag Manager, Vimeo, Woo Commerce, reCAPTCHA, Google Analytics, WordPress.org, Nginx, Mobile Friendly
2007